Brian Abrahams

Stock Analyst at RBC Capital

(0)
# 3980
Out of 5,218 analysts
461
Total ratings
38.94%
Success rate
-2.77%
Average return
40 Stocks
Name Action Price Target Current % Upside Ratings Updated
Gilead Sciences
Reiterates: Sector Perform
84 84
91.85 -8.55% 29 Dec 11, 2024
Applied Therapeutics
Downgrades: Sector Perform
12 4
1.15 247.83% 4 Nov 29, 2024
Neumora Therapeutics
Reiterates: Outperform
29 29
10.29 181.83% 5 Nov 22, 2024
Sage Therapeutics
Upgrades: Sector Perform
4 4
5.34 -25.09% 21 Nov 21, 2024
Incyte
Maintains: Sector Perform
80 74
68.61 7.86% 19 Nov 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
50 48
2.14 2142.99% 10 Nov 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
32 31
13.74 125.62% 3 Nov 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sector Perform
437 451
463.5 -2.7% 48 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
10 10
7.5 33.33% 15 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
1260 1215
730.7 66.28% 30 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sector Perform
32 30
26.76 12.11% 11 Nov 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sector Perform
3 1
0.26 284.62% 8 Oct 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
182 182
123.57 47.28% 31 Oct 21, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
17 20
7.52 165.96% 14 Oct 18, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Sector Perform
133 133
126.68 4.99% 16 Oct 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sector Perform
32 34
46.45 -26.8% 17 Oct 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
106 108
83.02 30.09% 18 Oct 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
292 269
150.04 79.29% 32 Oct 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
82 82
15.13 441.97% 7 Sep 20, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
55 55
40.07 37.26% 13 Sep 3, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sector Perform
28 24
12.79 87.65% 9 Aug 9, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
3 3
0.7 328.57% 9 Aug 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sector Perform
13 12
7.7 55.84% 14 Aug 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Outperform
22 22
7.13 208.56% 9 Jun 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
54 45
13.2 240.91% 11 May 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
33 32
n/a n/a 3 Nov 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
235 225
n/a n/a 7 Nov 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sector Perform
25 15
6.06 147.52% 14 Oct 2, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sector Perform
12 19
n/a n/a 13 Sep 27, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sector Perform
12 9
1.35 566.67% 3 Mar 31, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sector Perform
21 33
42.8 -22.9% 3 Nov 3, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sector Perform
50 34
n/a n/a 2 Jun 17, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
25
n/a n/a 1 Oct 12, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
320
n/a n/a 1 Jun 16, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sector Perform
9 6
n/a n/a 2 Feb 22, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Outperform
120 118
n/a n/a 2 May 7, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
66 0
n/a n/a 3 Dec 4, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sector Perform
n/a
n/a n/a 2 Nov 2, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sector Perform
92
n/a n/a 1 Sep 15, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
17
n/a n/a 1 Sep 15, 2017